Objective: To assess the risk of ocular damage from 4 types of light curing units (LCUs) and to estimate the maximum permissible ocular exposure times from each LCU during an 8-hour workday.
Methods: Extracted human maxillary teeth were mounted in a dentoform. Four types of LCUs (plasma arc, low-power and high-power light-emitting diode, and quartz-tungsten-halogen) were used to cure a simulated restoration in the maxillary central incisor from the facial and palatal aspects. To simulate ocular exposure, the spectral irradiance (W/[cm2 · nm]) from the LCUs was measured 5 times at each of 3 distances (30 cm, 50 cm and 100 cm) from the tooth, using a cosine-corrected probe attached, via a fibre optic cable, to a calibrated spectroradiometer. The weighted blue-light and effective ultraviolet (UV) irradiances that would be received by the eye from each LCU were calculated.
Results: The maximum permissible daily exposure limits for UV light exceeded 8 hours at all distances and orientations. The maximum permissible cumulative daily exposure time to blue light was as low as 6 seconds when curing from the palatal aspect with the plasma arc LCU and as high as 1.5 hours when the low-power light-emitting diode LCU was used from the facial aspect.
Conclusions: The 4 LCUs tested did not pose a risk of UV-mediated ocular damage. The higher-powered lamps showed potential to cause blue-light-mediated ocular damage at shorter distances, with damage potentially occurring after cumulative viewing of only 6 seconds at the 30-cm distance during an 8-hour workday.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Longitudinal assessment of retinal and visual pathway electrophysiology and structure after high altitude exposure.
Graefes Arch Clin Exp Ophthalmol
January 2025
Institute of Brain Diseases and Cognition, School of Medicine, Xiamen University, Xiamen, 361102, Fujian, China.
High altitude (HA) exposure induces impairments in visual function. This study was designed to dynamically observe visual function after returning to lowland and elucidate the underlying mechanism by examining the structure and function of retina and visual pathway. Twenty-three subjects were recruited before (Test 1), and one week (Test 2) and three months (Test 3) after their return from HA (4300 m) where they resided for 30 days.
View Article and Find Full Text PDFNociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
Surv Ophthalmol
January 2025
Michigan Medicine, Department of Ophthalmology and Visual Sciences, Ann Arbor, MI, USA.
Chronic ocular surface pain (COSP) refers to interrelated symptoms such as eye burning, aching, and irritation and can occur as an isolated condition or comorbid with numerous ocular disorders, including dry eye syndrome Treatments for COSP are largely aimed at the ocular surface and modulating pain arising from damaged corneal nerves; however, the average impact of these treatments on COSP are low to absent. A potential explanation for this is that in a subset of patients with COSP, individuals have amplified and/or dysregulated neural signaling and sensory processing within the central nervous system (CNS). As in other chronic pain conditions, this might be the pathogenic mechanism primarily responsible for maintaining pain - a phenomenon now referred to as nociplastic pain.
View Article and Find Full Text PDFRadius-Maumenee syndrome (idiopathic dilated episcleral vessels).
GMS Ophthalmol Cases
December 2024
Universidade Federal do Paraná (UFPR), Curitiba, Brazil.
Purpose: Idiopathic elevated episcleral venous pressure (IEEVP) or Radius-Maumenee syndrome (RMS) is a rare disease without any identified underlying cause. An increasing episcleral venous pressure (EVP) leads to raised intraocular pressure (IOP) and consequently glaucomatous damage of the optic nerve. The objective of this paper is to report this rare condition as well as its clinical management.
View Article and Find Full Text PDFEye Axial Length: Is There a Protective Link to Diabetic Retinopathy?
Cureus
December 2024
Optics and Optometry Division, Investigative Techniques in Optometry Research Group, Department of Biomedical Sciences, University of West Attica, Athens, GRC.
Diabetic retinopathy (DR) is a leading cause of vision impairment and blindness globally, particularly among working-age adults. As the prevalence of diabetes continues to rise, understanding factors that influence DR development and progression is increasingly important. Recent studies suggest a protective association between a longer axial length (AL) of the eye and the risk of DR, particularly in myopic individuals.
View Article and Find Full Text PDFNanoengineered mitochondria enable ocular mitochondrial disease therapy the replacement of dysfunctional mitochondria.
Acta Pharm Sin B
December 2024
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Leber's hereditary optic neuropathy (LHON) is an ocular mitochondrial disease that involves the impairment of mitochondrial complex I, which is an important contributor to blindness among young adults across the globe. However, the disorder has no available cures, since the approved drug idebenone for LHON in Europe relies on bypassing complex I defects rather than fixing them. Herein, mRNA-loaded nanoparticle (mNP)-engineered mitochondria (mNP-Mito) were designed to replace dysfunctional mitochondria with the delivery of exogenous mitochondria, normalizing the function of complex I for treating LHON.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!